1. Home
  2. CRC vs IOVA Comparison

CRC vs IOVA Comparison

Compare CRC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$54.42

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$10.18

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
IOVA
Founded
2014
2007
Country
United States
United States
Employees
2500
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
1.7B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
CRC
IOVA
Price
$54.42
$10.18
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$72.57
$9.00
AVG Volume (30 Days)
769.2K
13.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$3,669,000,000.00
N/A
Revenue This Year
$12.37
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
14.73
N/A
52 Week Low
$43.25
$1.76
52 Week High
$71.98
$10.98

Technical Indicators

Market Signals
Indicator
CRC
IOVA
Relative Strength Index (RSI) 51.07 72.59
Support Level $50.42 $3.57
Resistance Level $55.01 N/A
Average True Range (ATR) 1.59 0.47
MACD -0.01 0.06
Stochastic Oscillator 41.51 72.29

Price Performance

Historical Comparison
CRC
IOVA

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: